Pay in 4 interest-free payments of $5.18 Learn more
Ships within 48 hours · Estimated delivery Aug 12 - Aug 17
In published preclinical work, inhibiting NNMT is associated with elevated intracellular NAD and SAM, reduced lipogenesis and smaller adipocytes in cell and diet-induced-obese rodent models, and is studied in the context of insulin sensitivity and muscle function
Offer a non-stimulant alternative to traditional weight loss medications
Compound Overview AOD-9604 is a synthetic peptide studied in biochemical research for its interaction with signalling pathways and regulatory systems
When evaluating lipotropic injection results , its important to consider the broader weight management strategy , not just the injectable component
(jofem.org) Is AOD-9604 better than semaglutide or tirzepatide
Microbiota and gut-liver axis: their influences on obesity and obesity-related liver disease
US$ 20.55
US$ 28.24
US$ 28.35
US$ 27.23
US$ 20.44
US$ 23.27
